794P Efficacy and tolerability of neoadjuvant treatment with T-VEC in difficult to resect primary basal cell carcinoma: A phase II clinical trial (NeoBCC)

794P Efficacy and tolerability of neoadjuvant treatment with T-VEC in difficult to resect primary basal cell carcinoma: A phase II clinical trial (NeoBCC)

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 33; p. S907
Main Authors: Ressler, J.M., Kusienicka, A., Silmbrod, R., Silly, T., Bachmayr, V., Plaschka, M., Shaw, L.E., Zila, N., Stepan, A., Tschandl, P., Tittes, J., Roka, F., Haslik, W., Koenig, F., Kunstfeld, R., Petzelbauer, P., Halbritter, F., Weninger, W., Farlik, M., Hoeller, C.
Format: Journal Article
Language:English
Published: 01-09-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
DOI:10.1016/j.annonc.2022.07.920